VP1
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 360 PDB declaration: 360-meric(360) Consistent with protein copy count | Chain 1; UniProt 579–878 Chain 2; UniProt 70–340 Chain 3; UniProt 341–578 Chain 4; UniProt 2–69 | Not recorded | 2E1 Heavy Chain × 60 2E1 Light Chain × 60 PLM PALMITIC ACID × 60 | ELECTRON MICROSCOPY cryo-EM buffer:pH 8 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 2.95 Å |
| 2 | Protein heterocomplex Heteromer Protein × 6 PDB declaration: hexameric(6) Consistent with protein copy count | Chain 1; UniProt 579–878 Chain 2; UniProt 70–340 Chain 3; UniProt 341–578 Chain 4; UniProt 2–69 | Not recorded | 2E1 Heavy Chain × 1 2E1 Light Chain × 1 PLM PALMITIC ACID × 1 | ELECTRON MICROSCOPY cryo-EM buffer:pH 8 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 2.95 Å |
| 3 | Protein heterocomplex Heteromer Protein × 30 PDB declaration: 30-meric(30) Consistent with protein copy count | Chain 1; UniProt 579–878 Chain 2; UniProt 70–340 Chain 3; UniProt 341–578 Chain 4; UniProt 2–69 | Not recorded | 2E1 Heavy Chain × 5 2E1 Light Chain × 5 PLM PALMITIC ACID × 5 | ELECTRON MICROSCOPY cryo-EM buffer:pH 8 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 2.95 Å |
| 4 | Protein heterocomplex Heteromer Protein × 36 PDB declaration: 36-meric(36) Consistent with protein copy count | Chain 1; UniProt 579–878 Chain 2; UniProt 70–340 Chain 3; UniProt 341–578 Chain 4; UniProt 2–69 | Not recorded | 2E1 Heavy Chain × 6 2E1 Light Chain × 6 PLM PALMITIC ACID × 6 | ELECTRON MICROSCOPY cryo-EM buffer:pH 8 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 2.95 Å |
| 5 | Protein heterocomplex Heteromer Protein × 6 PDB declaration: hexameric(6) Consistent with protein copy count | Chain 1; UniProt 579–878 Chain 2; UniProt 70–340 Chain 3; UniProt 341–578 Chain 4; UniProt 2–69 | Not recorded | 2E1 Heavy Chain × 1 2E1 Light Chain × 1 PLM PALMITIC ACID × 1 | ELECTRON MICROSCOPY cryo-EM buffer:pH 8 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 2.95 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 9OCO | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1PIV BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14 Deposited 1995-02-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: complete icosahedral assembly |
Chain 1
577–877(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1PIV BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14 Deposited 1995-02-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
577–877(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1PIV BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14 Deposited 1995-02-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 1
577–877(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1PIV BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14 Deposited 1995-02-02 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 1
577–877(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1PIV BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14 Deposited 1995-02-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
577–877(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1PIV BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14 Deposited 1995-02-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 75 PDB declaration: 75-meric |
Chain 1
577–877(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 15 MYR MYRISTIC ACID × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1PVC REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-03-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: 300-MERIC |
Chain 2
70–340(271 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SPH SPHINGOSINE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1PVC REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-03-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 2
70–340(271 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1PVC REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-03-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 2
70–340(271 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SPH SPHINGOSINE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1PVC REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-03-30 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 2
70–340(271 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SPH SPHINGOSINE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1PVC REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-03-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 2
70–340(271 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SPH SPHINGOSINE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1PVC REFINEMENT OF THE SABIN STRAIN OF TYPE 3 POLIOVIRUS AT 2.4 ANGSTROMS AND THE CRYSTAL STRUCTURES OF ITS VARIANTS AT 2.9 ANGSTROMS RESOLUTION Deposited 1995-03-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 75 PDB declaration: 75-meric |
Chain 2
70–340(271 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SPH SPHINGOSINE × 15 MYR MYRISTIC ACID × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1VBA POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: complete icosahedral assembly |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBA POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBA POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBA POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBA POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBA POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 75 PDB declaration: 75-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 15 MYR MYRISTIC ACID × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1VBB POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: complete icosahedral assembly |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBB POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBB POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBB POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 Deposited 1996-01-02 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBB POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBB POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 75 PDB declaration: 75-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J80 (METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE × 15 MYR MYRISTIC ACID × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBC POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: complete icosahedral assembly |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBC POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBC POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBC POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 Deposited 1996-01-02 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBC POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBC POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 Deposited 1996-01-02 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 75 PDB declaration: 75-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Not recorded | J77 (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE × 15 MYR MYRISTIC ACID × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBE POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: complete icosahedral assembly |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBE POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBE POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBE POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBE POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 1VBE POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 Deposited 1996-01-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 75 PDB declaration: 75-meric |
Chain 1
578–877(300 aa)
Chain 2
69–339(271 aa)
Chain 3
340–574(235 aa)
Chain 4
1–68(68 aa)
|
Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L Mutation:CHAIN 1, F124L, F134L | J78 (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE × 15 MYR MYRISTIC ACID × 15 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.80 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: 300-meric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYB Poliovirus early RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: 300-meric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 3IYC Poliovirus late RNA-release intermediate Deposited 2009-07-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric |
Chain 2
83–96(14 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl;pH 7.4;20mM Tris pH 7.4, 2mM CaCl2, 20mM NaCl
cryo-EM vitrification conditions
blot for 3 secs;Cryogen ETHANE
|
Resolution 10.00 Å |
| 8E8R 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 360 PDB declaration: 360-meric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.66 Å |
| 8E8R 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.66 Å |
| 8E8R 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.66 Å |
| 8E8R 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 36 PDB declaration: 36-meric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.66 Å |
| 8E8R 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-25 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.66 Å |
| 8E8X 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-26 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 360 PDB declaration: 360-meric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.91 Å |
| 8E8X 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-26 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.91 Å |
| 8E8X 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-26 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 5 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.91 Å |
| 8E8X 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-26 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 36 PDB declaration: 36-meric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 6 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.91 Å |
| 8E8X 9H2 Fab-Sabin poliovirus 3 complex Deposited 2022-08-26 | Different construct Different mutation/modification Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain 2
78–340(263 aa)
|
Not recorded | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.91 Å |
| 9OD3 SIPV3-6B5 Complex Deposited 2025-04-25 | Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain 1
579–878(300 aa)
Chain 2
70–340(271 aa)
Chain 3
341–578(238 aa)
Chain 4
2–69(68 aa)
|
Not recorded | PLM PALMITIC ACID × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.94 Å |
11 other PDB entries and 57 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | POLG_POL3L |
| Isoform | — |
| PDB entities | 1, 2, 3, 4 |
| Chains and sequence ranges | Author chain 1; PDBConstruct 1–300; UniProt 579–878 Author chain 2; PDBConstruct 1–271; UniProt 70–340 Author chain 3; PDBConstruct 1–238; UniProt 341–578 Author chain 4; PDBConstruct 1–68; UniProt 2–69 |